National survey of ovarian carcinoma IV: Patterns of care and related survival for older patients

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Cancer

• Publication date

  1994-01-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/1097-0142(19940115)73:2<377::AID-CNCR2820730223>3.0.CO;2-#PMID 8293403
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Age does not influence taxol dose intensity in recurrent carcinoma of the ovary

  2010cited by this paper
• Ovarian cancer: Survival and treatment differences by age

  2010cited by this paper
• Treatment of ovarian cancer in elderly women: Mayo clinic–north central cancer treatment group studies

  2010cited by this paper
• Cancer of the ovary.

  1994cited by this paper
• Ovarian cancer. Age contrasts in incidence, histology, disease stage at diagnosis, and mortality.

  1993cited by this paper
• Cancer statistics, 1993

  1993cited by this paper
• National survey of ovarian carcinoma. I. A patient care evaluation study of the American College of Surgeons.

  1993cited by this paper
• Molecular genetics for the clinician

  1993cited by this paper
• Preliminary report of the national cancer data base

  1991cited by this paper
• Ovarian cancer. Advances in management.

  1991cited by this paper
• Cancer statistics, 1991

  1991cited by this paper
• Ovarian carcinoma.Advances in diagnosis, staging, and treatment

  1990cited by this paper
• The influence of cytoreductive surgery on progression-free interval and survival in epithelial ovarian cancer.

  1989cited by this paper
• Surgical staging of carcinoma of the ovaries.

  1989cited by this paper
• Chemotherapy in ovarian carcinoma: present role and future prospects.

  1989cited by this paper
• Age as a risk factor for inadequate treatment.

  1988cited by this paper
• Aggressive management of cancer in the elderly.

  1988cited by this paper
• Age as a risk factor for inadequate treatment.

  1987cited by this paper
• Lung cancer in the elderly.

  1986cited by this paper
• Choice of cancer therapy varies with age of patient.

  1986cited by this paper
• Ovarian cancer.

  1986cited by this paper
• Ovarian cancer in the elderly: an analysis of Surveillance, Epidemiology, and End Results Program data.

  1986cited by this paper
• Willy Alfred Borgeaud: Fasti Vmbrici. Étudessur le vocabulaire et le rituel des Tables eugubines. (Collection d'études anciennes de l'Université d'Ottawa, 1.) Pp. 264. Ottawa, Ontario: Éditions de l'Université d'Ottawa, 1982. Paper, $19.

  1986cited by this paper
• Relationship Between Age at Diagnosis and Treatments

  1985cited by this paper
• Surgical considerations in ovarian cancer.

  1985cited by this paper
• Surgical considerations in ovarian cancer.

  1985cited by this paper
• Surgical Procedures in Patients Aged 90 Years and Older

  1984cited by this paper
• Surgical procedures in patients aged 90 years and older.

  1984cited by this paper
• Chemotherapy of ovarian cancer.

  1984cited by this paper
• Stage III epithelial ovarian cancer: the role of maximal surgical reduction.

  1984cited by this paper
• Carcinoma of the Breast in the Extremes of Age

  1984cited by this paper
• Primary Cytoreductive Surgery for Epithelial Ovarian Cancer

  1983cited by this paper
• Cancer : Principles and Practice of Oncology

  1982cited by this paper
• Cancer Stage‐to‐Age Relationship: Implications for Cancer Screening in the Elderly *

  1981cited by this paper
• Cancer incidence and mortality in the United States, 1973-77.

  1981cited by this paper
• Surveillance, epidemiology, and end results: incidence and mortality data, 1973-77.

  1981cited by this paper
• Thoracotomy in patients over age seventy years: ten-year experience.

  1981cited by this paper
• Chemotherapy of ovarian cancer.

  1978cited by this paper
• Major pulmonary resection for bronchogenic carcinoma in the elderly.

  1976cited by this paper
• Preoperative and Intraoperative Evaluation in Ovarian Malignancy

  1976cited by this paper
• Third national cancer survey: incidence data.

  1975cited by this paper
• Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma.

  1975cited by this paper
• A computer program for comparing K samples with right-censored data.

  1972cited by this paper
• Age-ism: another form of bigotry.

  1969cited by this paper

• Recommandations pour la pratique clinique Nice-Saint Paul de Vence 2024–2025 : prise en charge du cancer épithélial de l’ovaire de haut grade

  2026cites this paper
• Unveiling the role of extracellular matrix elements and regulators in shaping ovarian cancer growth and metastasis.

  2025cites this paper
• Peritoneal cavity-derived small extracellular vesicles from aged tumor-naïve hosts promote ovarian cancer adhesion and invasion

  2025cites this paper
• Examining the impact of age on chemotherapy completion in epithelial ovarian, fallopian tube and primary peritoneal cancer: a retrospective cohort study in Thailand

  2024cites this paper
• Muscle loss during cancer therapy is associated with poor outcomes in advanced ovarian cancer.

  2023cites this paper
• Ovarian cancer in the older patient: where are we now? What to do next?

  2023cites this paper
• The effect of older age on treatment outcomes in women with advanced ovarian cancer receiving chemotherapy: An NRG-Oncology/Gynecologic Oncology Group (GOG-0182-ICON5) ancillary study.

  2023cites this paper
• Multi-Disciplinary Care Planning of Ovarian Cancer in Older Patients: General Statement—A Position Paper from SOFOG-GINECO-FRANCOGYN-SFPO

  2022cites this paper
• Association between Serum Biomarkers with Postoperative Complications and Delay of Adjuvant Chemotherapy Initiation in Ovarian Cancer Patients Undergoing Primary Cytoreductive Surgery: A Pilot Study

  2022cites this paper
• Quality is more important than quantity: pre-operative sarcopenia is associated with poor survival in advanced ovarian cancer

  2022cites this paper
• Real-world treatment patterns of maintenance therapy in platinum-sensitive recurrent ovarian cancer.

  2021cites this paper
• Advanced ovarian cancer patients identify opportunities for prehabilitation: A qualitative study

  2021cites this paper
• Prognostic significance of ethnicity and age in advanced stage epithelial ovarian cancer: An NRG oncology/gynecologic oncology group study.

  2021cites this paper
• Development and Validation of Prognostic Nomogram for Primary Peritoneal Serous Carcinoma Compared With FIGO Staging System: A Population-Based Study

  2021cites this paper
• Age-Related Considerations in Cardio-Oncology

  2020cites this paper
• Management and Survival of Elderly and Very Elderly Patients with Ovarian Cancer: An Age-Stratified Study of 1123 Women from the FRANCOGYN Group

  2020cites this paper
• Chemotherapy alone for patients 75 years and older with epithelial ovarian cancer - is interval cytoreductive surgery still needed?

  2020cites this paper
• Ovarian Cancer in the Older Woman

  2020cites this paper
• Carcinoma of the Ovaries and Fallopian Tubes

  2020cites this paper
• [Epithelial ovarian cancer and elderly patients. Article drafted from the French Guidelines in oncology entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY under the aegis of CNGOF and endorsed by INCa].

  2019cites this paper
• Management of endometrial, ovarian and cervical cancer in the elderly: current approach to a challenging condition

  2018cites this paper
• Management of Gynecologic Malignancies in the Elderly Women

  2018cites this paper
• Origins based clinical and molecular complexities of epithelial ovarian cancer.

  2018cites this paper
• Pre-operative assessment and post-operative outcomes of elderly women with gynecologic cancers, primary analysis of NRG CC-002: An NRG oncology group/gynecologic oncology group study.

  2018cites this paper
• Aging Increases Susceptibility to Ovarian Cancer Metastasis in Murine Allograft Models and Alters Immune Composition of Peritoneal Adipose Tissue1

  2018cites this paper
• Chemotherapy completion in elderly women with ovarian, primary peritoneal or fallopian tube cancer - An NRG oncology/Gynecologic Oncology Group study.

  2017cites this paper
• Application of combined intraperitoneal and intravenous neoadjuvant chemotherapy in senile patients with advanced ovarian cancer and massive ascites.

  2017cites this paper
• Evaluation of the efficacy and toxicity profile associated with intraperitoneal chemotherapy use in older women.

  2017cites this paper
• Ovarian Cancer in the Elderly

  2017cites this paper
• How to Design Clinical Trials

  2016cites this paper
• Improving outcomes for older women with gynaecological malignancies.

  2016cites this paper
• Ovarian Cancer Treatment Decisions: Accessing Gynecologic Oncology Care

  2016cites this paper
• Ovarian cancer in the older woman.

  2016cites this paper
• Prognostic factors in young ovarian cancer patients: An analysis of four prospective phase III intergroup trials of the AGO Study Group, GINECO and NSGO.

  2016cites this paper
• Ovarian Cancer in Elderly Patients

  2016cites this paper
• Delay in chemotherapy administration impacts survival in elderly patients with epithelial ovarian cancer.

  2015cites this paper
• Treatment of ovarian cancer in the older woman.

  2015cites this paper
• Epithelial ovarian cancer in older women: defining the best management approach.

  2015cites this paper
• Under-treatment of elderly patients with ovarian cancer: a population based study

  2015cites this paper
• Primary debulking surgery for advanced ovarian cancer: are you a believer or a dissenter?

  2014cites this paper
• Estudio comparativo entre cirugía primaria y cirugía de intervalo en el estadio iiic del cáncer de ovario

  2014cites this paper
• Breast and ovarian cancer in the older woman.

  2014cites this paper
• Wpływ procesu starzenia się ludzkiego mezotelium otrzewnowego na wykładniki progresji raka jajnika w modelu komórkowym i zwierzęcym

  2014cites this paper
• CA125 Level Association With Chemotherapy Toxicity and Functional Status in Older Women With Ovarian Cancer

  2013cites this paper
• Considerations Regarding the Administration of Systemic Therapy for Elderly Patients With Ovarian Cancer

  2013cites this paper
• Does neoadjuvant chemotherapy decrease the risk of hospital readmission following debulking surgery?

  2013cites this paper
• Geriatric Issues in Ovarian Cancer

  2013cites this paper
• VAV1 represses E-cadherin expression through the transactivation of Snail and Slug: a potential mechanism for aberrant epithelial to mesenchymal transition in human epithelial ovarian cancer.

  2013cites this paper
• Preoperative Risk Assessment

  2013cites this paper
• Ovarian Cancer: Primary Chemotherapy

  2013cites this paper
• Treatment of Endometrial Cancer in the Geriatric Patient

  2013cites this paper
• Wpływ syntetycznych pochodnych resweratrolu, 3,3',4,4'-tetrahydroksy-trans-stilbenu i 3,3',4,4',5,5'-heksahydroksy-trans-stilbenu, na wykładniki inwazyjności komórek raka jajnika w modelu in vitro

  2013cites this paper
• Neoadjuvant chemotherapy (NACT) is an effective way of managing elderly women with advanced stage ovarian cancer (FIGO Stage IIIC and IV)

  2013cites this paper
• Ovarian Cancer: Surgical Considerations

  2013cites this paper
• Clinical Trials in Elderly Ovarian Cancer Patients – Does It Make Sense?

  2012cites this paper
• Doublet chemotherapy in the elderly patient with ovarian cancer.

  2012cites this paper
• Effect of Radical Cytoreductive Surgery on Omission and Delay of Chemotherapy for Advanced-Stage Ovarian Cancer

  2012cites this paper
• Chemotherapy Treatment Patterns in Elderly Patients Initially Diagnosed With Advanced Ovarian Cancer

  2012cites this paper
• Considerations in the Surgical Management of Ovarian Cancer in the Elderly

  2012cites this paper
• Elderly and very elderly advanced ovarian cancer patients: does the age influence the surgical management?

  2012cites this paper
• Clinical aspects of the management of elderly women diagnosed with gynecologic malignancies: Treatment decisions and choices

  2011cites this paper
• Oncogériatrie : quelle réalité aujourd’hui ?

  2011cites this paper
• Morbidity, mortality and overall survival in elderly women undergoing primary surgical debulking for ovarian cancer: a delicate balance requiring individualization.

  2011cites this paper
• Completion of adjuvant chemotherapy and use of health services for older women with epithelial ovarian cancer.

  2011cites this paper
• Defining the limits of radical cytoreductive surgery for ovarian cancer.

  2011cites this paper
• The National Cancer Database report on advanced-stage epithelial ovarian cancer: impact of hospital surgical case volume on overall survival and surgical treatment paradigm.

  2010cites this paper
• Ovarian Carcinoma: Diagnostic Immunohistochemistry of MUCIN4 (MUC4)

  2010cites this paper
• Use of adjuvant 5-fluorouracil and radiation therapy after gastric cancer resection among the elderly and impact on survival.

  2010cites this paper
• Use of laparoscopy in older women undergoing gynecologic procedures: is it time to overcome initial concerns?

  2010cites this paper
• The Impact of Age on the Treatment and Survival of Ovarian Cancer Patients

  2010cites this paper
• The effect of age on the tolerability of intraperitoneal chemotherapy, complication rate, and survival in patients with ovarian cancer.

  2010cites this paper
• Perioperative morbidity of gynecologic surgery in the elderly

  2009cites this paper
• Adjuvant chemotherapy for the “oldest old” ovarian cancer patients

  2009cites this paper
• Ovarian Cancer Cytoreductive Surgery in the Elderly

  2009cites this paper
• Poor outcome of elderly patients with platinum-sensitive recurrent ovarian cancer: results from the SOCRATES retrospective study.

  2009cites this paper
• Immunopathogenesis of ovarian cancer.

  2009cites this paper
• EMBRYONIC STEM CELLS / INDUCED PLURIPOTENT STEM CELLS RNA Polymerase II Associated Factor 1 / PD 2 Maintains Self-Renewal by Its Interaction with Oct 3 / 4 in Mouse Embryonic Stem Cells

  2009cites this paper
• Chemotherapy for Ovarian Cancer in the Older Adult

  2009cites this paper
• The effect of comorbidity on survival in patients with advanced ovarian cancer

  2009cites this paper
• Ovarian cancer in the octogenarian: does the paradigm of aggressive cytoreductive surgery and chemotherapy still apply?

  2008cites this paper
• Human PAF complexes in endocrine tumors and pancreatic cancer

  2008cites this paper
• Ovarian cancer in older women.

  2008cites this paper
• A phase II study of weekly carboplatin and paclitaxel as first-line treatment of elderly patients with advanced ovarian cancer. A Multicentre Italian Trial in Ovarian cancer (MITO-5) study.

  2008influential citation
• [Clinical characteristics and prognosis of epithelial ovarian cancer in young women].

  2008cites this paper
• A study of the predictive value of morphometric assessments in clinical outcome in ovarian epithelial malignancy

  2007cites this paper
• Response and outcomes in elderly patients with stages IIIC-IV ovarian cancer receiving platinum-taxane chemotherapy.

  2007cites this paper
• Pathologic findings and outcomes for octogenarians presenting with uterine malignancy.

  2007cites this paper
• Advanced epithelial ovarian cancer in the elderly: chemotherapy tolerance and outcome.

  2007cites this paper
• Young Age Is Associated with Favorable Characteristics but Is Not an Independent Prognostic Factor in Patients with Epithelial Ovarian Cancer: A Single Institution Experience

  2006cites this paper
• Traitement des cancers ovariens chez la femme âgée de plus de 70 ans

  2006cites this paper
• Progressive epithelial ovarian carcinoma

  2006cites this paper
• Improved Survival of Asians With Corpus Cancer Compared With Whites: An Analysis of Underlying Factors

  2006cites this paper
• Ovarian cancer in older women

  2006influential citation
• Impact of age on outcome in patients with advanced ovarian cancer treated within a prospectively randomized phase III study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR).

  2006cites this paper
• Epithelial ovarian carcinoma in younger vs older women: is age an independent prognostic factor? The Hellenic Oncology Cooperative Group experience

  2006cites this paper
• Progressive epithelial ovarian carcinoma. Prognostic factors and clinical management.

  2006cites this paper
• Variation in chemotherapy utilization in ovarian cancer: the relative contribution of geography.

  2006cites this paper
• Predictors of surgical outcome and survival among elderly women diagnosed with ovarian and primary peritoneal cancer.

  2006cites this paper
• Ovarian cancer in the elderly: feasibility of surgery and chemotherapy in 89 geriatric patients

  2006cites this paper
• Prise en charge des cancers solides et des hémopathies malignes du sujet âgé : l'oncogériatrie, une discipline en devenir. Seconde partie : traitement des cancers solides (partie 2) et des hémopathies malignes du sujet âgé

  2005cites this paper